A Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma
NCT03834584
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class
Stopped
Terminated due to sponsor decision.
Conditions
Lymphoma
Interventions
DRUG:
AG-636
Sponsor
Agios Pharmaceuticals, Inc.